Kite Pharma (KITE) Tops Q3 EPS by 51c

November 9, 2016 9:00 AM EST
Get Alerts KITE Hot Sheet
Trade KITE Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Kite Pharma (NASDAQ: KITE) reported Q3 EPS of ($1.10), $0.51 better than the analyst estimate of ($1.61). Revenue for the quarter came in at $7.34 million versus the consensus estimate of $4.94 million.

For earnings history and earnings-related data on Kite Pharma (KITE) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment